Skip to main content

Drugs

Ausgabe 22/2003

Inhalt (16 Artikel)

Leading Article

Advances in the Understanding and Treatment of Nonalcoholic Fatty Liver Disease

Stephen A. Harrison, Adrian M. Di Bisceglie

Adis Drug Profile

Emtricitabine

Lynne M. Bang, Lesley J. Scott

Adis Drug Profile

Emtricitabine

Raymond F. Schinazi

Adis Drug Profile

Emtricitabine

Erik De Clercq

Adis Drug Profile

Miglustat

Paul L. McCormack, Karen L. Goa

Adis Drug Profile

Miglustat

Ernest Beutler

Adis Drug Profile

Miglustat

Frances M. Platt, Terry D. Butters

Adis Drug Profile

Miglustat

Timothy M. Cox

Adis Device Profile

Novolizer®

Caroline Fenton, Gillian M. Keating, Greg L. Plosker

Adis Drug Profile

Novolizer®

Peter Haidl

Adis Drug Profile

Novolizer®

Adrian Gillissen

Adis Drug Evaluation

Lercanidipine

Lynne M. Bang, Therese M. Chapman, Karen L. Goa

Adis Drug Evaluation

Octreotide Long-Acting Release (LAR)

Kate McKeage, Susan Cheer, Antona J. Wagstaff

Adis Drug Evaluation

Inhaled Tobramycin (TOBI®)

Susan M. Cheer, John Waugh, Stuart Noble

Adis Drug Evaluation

Verteporfin

Susan J. Keam, Lesley J. Scott, Monique P. Curran

Aktuelle Ausgaben